Shape Therapeutics

Shape Therapeutics

  • Founded: 2018
  • Location: Seattle, WA
  • Employee range: 50 - 200
  • Clinical stage: RD
  • Therapy area: Genetic diseases
  • Drug types: GEN
  • Lead product: Undisclosed
  • Product link:
  • Funding: $112M B Jul 2021; $35.5M A Nov 2019

job board

Short description:

RNA-editing gene therapy

Drug notes:

Contact us to add description:

Long description:

Shape Therapeutics is developing RNA technologies to shape the future of gene therapies. To achieve this, Shape has built their gene therapy platform, comprising RNAskip, RNAfix and RNAswap payload technologies and tissue-specific AAVid delivery technology. Data output from the platform is then incorporated into Shape’s AI engine, where data drives decisions to select the next gene therapies that are scalable and curative for many diseases. This combination of cutting-edge science and drug development expertise is enabling Shape to advance breakthroughs in RNA editing to correct mutations, fine-tune gene expression and modulate protein interactions. Currently, Shape is focusing on therapies for Parkinson’s disease and the ocular disorder Stargardt disease.


Shape Therapeutics
Research Associate/Senior Research Associate, Rese...
Seattle, WA|58 days ago
Shape Therapeutics
Associate Scientist/Senior Associate Scientist, Ve...
Seattle, WA|100+ days ago
Shape Therapeutics
Scientist – Analytical Development
Seattle, WA|100+ days ago
Shape Therapeutics
Data Engineer
Seattle, WA|100+ days ago
Shape Therapeutics
(Sr.) Bioinformatics Associate Scientist
Seattle, WA|100+ days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy